The drug ACTILYSE contains
one active pharmaceutical ingredient (API):
This drug has been classified in the anatomical therapeutic chemical (ATC) classification
system as follows:
This drug has been assigned below unique identifiers within the countries it is being marketed:
BR
Câmara de Regulação do Mercado de Medicamentos
Identifier(s):
504500101153319, 504512030018303, 504512030018403
ES
Centro de información online de medicamentos de la AEMPS
Identifier(s):
59494
FI
Lääkealan turvallisuus- ja kehittämiskeskus
Identifier(s):
387675, 404491, 404533
FR
Base de données publique des médicaments
Identifier(s):
63617876, 67177673
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s):
344939, 48386, 48398, 48453
HK
Department of Health Drug Office
Identifier(s):
30511, 37894
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s):
1007453, 1061418, 1061419
NL
Z-Index G-Standaard
Identifier(s):
13250949, 13733370
NL
Z-Index G-Standaard, PRK
Identifier(s):
25747, 36870
NZ
Medicines and Medical Devices Safety Authority
Identifier(s):
13161, 4765, 4766, 4767
PL
Rejestru Produktów Leczniczych
Identifier(s):
100002579, 100002585, 100002622
SG
Health Sciences Authority
Identifier(s):
02340P
TN
Direction de la Pharmacie et du Médicament
Identifier(s):
5253111H, 5253112H, 5253113H